Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy

Cancer statistics, 2018

Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632

Prospective identification of tumorigenic breast cancer cells

Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839

Aging: a theory based on free radical and radiation chemistry

Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177

Mammalian MAP kinase signalling cascades

Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118

Triple-negative breast cancer: clinical features and patterns of recurrence

Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783

Triple-Negative Breast Cancer

Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,719

N6-methyladenosine-dependent regulation of messenger RNA stability

Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558

Mitochondria, Oxidants, and Aging

Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388

Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295

Signal transduction by the JNK group of MAP kinases

Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237

Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*

Pearson, G. W., Robinson, F. L., Gibson, T. B., Xu, B.-E., Karandikar, M. S., Berman, K. S., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,111

ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

Ginestier, C., Hur, M. H., Charafe‐Jauffret, E., Monville, F., Dutcher, J. A., Brown, M., Jacquemier, J. D., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,093

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905

ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility

Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092

Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA

He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776

Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α

Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint

Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413

The Biology of Chemokines and their Receptors

Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410

The Hippo Signaling Pathway in Development and Cancer

Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,317

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267

Hippo pathway in organ size control, tissue homeostasis, and cancer

Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206

Untitled work

(1999) · PubMed · Cited by 2,204

The cancer stem cell: premises, promises and challenges

Clevers, H. C. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,990

Role of CD47 as a Marker of Self on Red Blood Cells

Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,975

Gene expression regulation mediated through reversible m6A RNA methylation

Fu, Y., Dominissini, D., Rechavi, G., & He, C. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3724 · Cited by 1,961

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

Li, X., Lewis, M. T., Huang, J., Gutiérrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A. C., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,789

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752

Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties

Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,725

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,706

Radical causes of cancer

Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683

Applying the principles of stem-cell biology to cancer

Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1232 · Cited by 1,633

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550

Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains

Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501

Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte

Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473

Mitogen-activated protein kinases in apoptosis regulation

Wada, T., & Penninger, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207556 · Cited by 1,432

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Creighton, C. J., Li, X., Landis, M. D., Dixon, J. M., Neumeister, V. M., Sjolund, A. B., Rimm, D. L., Wong, H. H., Rodriguez, A. A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,414

FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity

Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311

N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells

Wang, Y., Li, Y., Toth, J. I., Petroski, M. D., Zhang, Z., & Zhao, J. C. (2014) · Nature Cell Biology · doi:10.1038/ncb2902 · Cited by 1,296

m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells

Batista, P. J., Molinié, B., Wang, J., Qu, K., Zhang, J., Li, L., Bouley, D. M., Lujan, E., Haddad, B., Daneshvar, K., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.09.019 · Cited by 1,276

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,210

Role of Glutathione in Cancer Progression and Chemoresistance

Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208

The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionPreprint

Zhao, B., Li, L., Lei, Q., & Guan, K. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,173

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,124

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

Baccelli, I., Schneeweiß, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,050

Heterogeneity in breast cancer

Polyák, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60534 · Cited by 1,038

Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression

Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993

Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA

Zhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 977

Hypoxia-Inducible Factors: Master Regulators of Cancer Progression

Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962

TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway

Lei, Q., Zhang, H., Zhao, B., Zha, Z., Bai, F., Pei, X., Zhao, S., Xiong, Y., & Guan, K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01874-07 · Cited by 956

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M. V., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 922

Integrin-associated protein (CD47) and its ligands

Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 880

Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche

Suda, T., Takubo, K., & Semenza, G. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.09.010 · Cited by 844

Coordinated histone modifications mediated by a CtBP co-repressor complex

Shi, Y. G., Sawada, J.-I., Sui, G., Affar, E. B., Whetstine, J. R., Lan, F., Ogawa, H., Luke, M. P.-S., Nakatani, Y., & Shi, Y. (2003) · Nature · doi:10.1038/nature01550 · Cited by 821

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

Kao, J., Salari, K., Bocanegra, M., Choi, Y.-L., Girard, L., Gandhi, J., Kwei, K. A., Hernandez-Boussard, T., Wang, P., Gazdar, A. F., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006146 · Cited by 788

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

Ginestier, C., Liu, S., Diebel, M. E., Körkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe‐Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 771

TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins

Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6778 · Cited by 758

Methylated nucleotides block 5′ terminus of HeLa cell messenger RNA

Wei, C.-M., Gershowitz, A., & Moss, B. A. (1975) · Cell · doi:10.1016/0092-8674(75)90158-0 · Cited by 751

Identification, Characterization, and Crystal Structure of the Omega Class Glutathione Transferases

Philip G. Board, Coggan, M., Chelvanayagam, G., Easteal, S., Jermiin, L. S., Schulte, G. K., Danley, D. E., Hoth, L. R., Griffor, M. C., Kamath, A. V., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001706200 · Cited by 736

Detection and Characterization of Tumor Hypoxia Using pO 2 Histography

Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728

Metastatic Stem Cells: Sources, Niches, and Vital Pathways

Óskarsson, T., Batlle, E., & Massagué, J. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.002 · Cited by 726

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Chan, K. S., Espinosa, Í., Chao, M. P., Wong, D. J., Ailles, L., Diehn, M., Gill, H. S., Presti, J. C., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 669

The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme

Krishnamurthy, P. C., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., & Schuetz, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313599200 · Cited by 668

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018866109 · Cited by 663

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 645

Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2

Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641

The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network

Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628

Hypoxia-Inducible Factor 1 and Cardiovascular Disease

Semenza, G. L. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170322 · Cited by 624

AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli

Falnes, P. Ø., Johansen, R., & Seeberg, E. C. (2002) · Nature · doi:10.1038/nature01048 · Cited by 617

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

Bhola, N. E., Balko, J. M., Dugger, T. C., Kuba, M. G., Sanchez, V. M., Sanders, M. E., Stanford, J. C., Cook, R. S., & Arteaga, C. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65416 · Cited by 606

Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis

Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C. M., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., & van der Wall, E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.309 · Cited by 602

TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition

Zhang, H., Liu, C., Zha, Z., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q., & Guan, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900843200 · Cited by 589

Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses

Jeffrey, K. L., Camps, M., Rommel, C., & Mackay, C. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2289 · Cited by 533

HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells

Mathieu, J., Zhang, Z., Zhou, W., Wang, A. J., Heddleston, J. M., Pinna, C. M. A., Hubaud, A., Stadler, B., Choi, M. P., Bar, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3320 · Cited by 532

Sox2 expression in breast tumours and activation in breast cancer stem cells

Leis, O., Eguiara, A., López‐Arribillaga, E., Alberdi, M. J., Hernández-García, S., Elorriaga, K., Pandiella, A., Rezola, R., & Martín, Á. G. (2011) · Oncogene · doi:10.1038/onc.2011.338 · Cited by 518

Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes

Walz, A., Peveri, P., Aschauer, H., & Baggiolini, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90432-3 · Cited by 506

CoREST is an integral component of the CoREST- human histone deacetylase complex

You, A., Tong, J. K., Grozinger, C. M., & Schreiber, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1454 · Cited by 500

Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells

Tsai, R. K., & Discher, D. E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708043 · Cited by 486

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion

Yu, F., Li, J., Chen, H., Fu, J., Ray, S. K., Huang, S., Zheng, H., & Ai, W. (2011) · Oncogene · doi:10.1038/onc.2010.591 · Cited by 477

Histological and molecular types of breast cancer: is there a unifying taxonomy?

Weigelt, B., & Reis-Filho, J. S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.166 · Cited by 472

Hypoxia inducible factors in cancer stem cells

Heddleston, J. M., Li, Z., Lathia, J. D., Bao, S., Hjelmeland, A. B., & Rich, J. N. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605551 · Cited by 471

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 467

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α

Seidel, S., Garvalov, B. K., Wirta, V., von Stechow, L., Schänzer, A., Meletis, K., Wolter, M., Sommerlad, D., Henze, A., Nistér, M., et al. (2010) · Brain · doi:10.1093/brain/awq042 · Cited by 462

Structure and regulation of MAPK phosphatases

Farooq, A., & Zhou, M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.12.008 · Cited by 460

Endothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial Interactions

Gimbrone, M. A., Obin, M. S., Brock, A., Luis, E., Hass, P. E., Hébert, C. A., Yip, Y. K., Leung, D. W., Lowe, D. G., Kohr, W. J., et al. (1989) · Science · doi:10.1126/science.2688092 · Cited by 452

Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells

Loh, Y.-H., Zhang, W., Chen, X., George, J., & Ng, H.-H. (2007) · Genes & Development · doi:10.1101/gad.1588207 · Cited by 443

The pharmacology of intracellular Ca2+-release channels

Ehrlich, B. E., Kaftan, E. J., Bezprozvannaya, S., & Борисович, Б. И. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90074-4 · Cited by 440

Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8.

Bazzoni, F., Cassatella, M. A., Rossi, F., Ceska, M., Dewald, B., & Baggiolini, M. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.771 · Cited by 436

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520032112 · Cited by 420

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

Hartman, Z. C., Poage, G. M., den Hollander, P., Tsimelzon, A. I., Hill, J. L., Panupinthu, N., Zhang, Y., Mazumdar, A., Hilsenbeck, S. G., Mills, G. B., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4524-t · Cited by 416

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF

Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2711 · Cited by 416

Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

Wang, Y., Liu, Y., Malek, S. N., Zheng, P., & Liu, Y. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.02.006 · Cited by 410

Significance of interleukin-6 (IL-6) in breast cancer (review)

Knüpfer, H., & Preiß, R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9328-3 · Cited by 410

Siah2 Regulates Stability of Prolyl-Hydroxylases, Controls HIF1α Abundance, and Modulates Physiological Responses to Hypoxia

Nakayama, K., Frew, I. J., Hagensen, M. K., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument‐Bromage, H., Tempst, P., Frappell, P. B., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.001 · Cited by 406

Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin

Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.21 · Cited by 402

Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia

Chao, M. P., Alizadeh, A. A., Tang, C. Z., Jan, M., Weissman-Tsukamoto, R., Zhao, F., Park, C. Y., Weissman, I. L., & Majeti, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2238 · Cited by 381

Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype

Semenza, G. L. (2016) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 380

The methylation state of poly A-containing-messenger RNA from cultured hamster cells

Dubin, D. T., & Taylor, R. H. (1975) · Nucleic Acids Research · doi:10.1093/nar/2.10.1653 · Cited by 373

Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres

Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373

Filling out the Hippo pathway

Saucedo, L. J., & Edgar, B. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2221 · Cited by 371

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling

Luo, M., Li, S., Brooks, M. D., Jiagge, E. M., Zhu, Y., Buschhaus, J. M., Conley, S. J., Fath, M. A., Davis, A., Gheordunescu, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.006 · Cited by 362

Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion

Chen, J., Imanaka, N., Chen, J., & Griffin, J. D. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605486 · Cited by 346

Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells

Mimeault, M., & Batra, S. K. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12004 · Cited by 339

Biology of hypoxia-inducible factor-2α in development and disease

Patel, S. A., & Simon, M. C. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.17 · Cited by 335

Emerging Roles of RNA Modification: m6A and U-Tail

Lee, M., Kim, B., & Kim, V. N. (2014) · Cell · doi:10.1016/j.cell.2014.08.005 · Cited by 333

MAP kinase phosphatases.

Theodosiou, A. M., & Ashworth, A. (2002) · Genome biology · doi:10.1186/gb-2002-3-7-reviews3009 · Cited by 321

Nomenclature for Mammalian Soluble Glutathione Transferases

Mannervik, B., Philip G. Board, Hayes, J. D., Listowsky, I., & Pearson, W. R. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)01001-3 · Cited by 313

Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia

Peng, F., Wang, J.-H., Fan, W.-J., Meng, Y.-T., Li, M.-M., Li, T.-T., Cui, B., Wang, H.-F., Zhao, Y. D., An, F., et al. (2017) · Oncogene · doi:10.1038/onc.2017.368 · Cited by 304

Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells

Samanta, D., Park, Y., Ni, X., Li, H., Zahnow, C. A., Gabrielson, E., Pan, F., & Semenza, G. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718197115 · Cited by 302

Positional cloning of ZNF 217 and NABC 1 : Genes amplified at 20q13.2 and overexpressed in breast carcinoma

Collins, C. C., Rommens, J. M., Kowbel, D., Godfrey, T. E., Tanner, M., Hwang, S.-I., Polikoff, D., Nonet, G. H., Cochran, J., Myambo, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8703 · Cited by 300

Coordination of m 6 A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming

Aguiló, F., Zhang, F., Sancho, A., Fidalgo, M., Cecilia, S. D., Vashisht, A. A., Lee, D., Chen, C., Rengasamy, M., Andino, B. E., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.09.005 · Cited by 290

Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer

Tang, Y.-A., Chen, Y.-F., Bao, Y., Mahara, S., Yatim, S. M. J. M., Oguz, G., Lee, P. L., Feng, M., Cai, Y., Tan, E. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801348115 · Cited by 277

Cancer stem cells and their role in metastasis

Shiozawa, Y., Nie, B., Pienta, K. J., Morgan, T. M., & Taichman, R. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.014 · Cited by 276

CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction

Zhao, X. W., van Beek, E. M., Schornagel, K., van der Maaden, H., van Houdt, M., Otten, M. A., Finetti, P., van Egmond, M., Matozaki, T., Kraal, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106550108 · Cited by 275

Emerging roles of TEAD transcription factors and its coactivators in cancers

Pobbati, A. V., & Hong, W. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23788 · Cited by 271

Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype

Lu, H., Samanta, D., Xiang, L., Zhang, H., Hu, H., Chen, I., Bullen, J. W., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513433112 · Cited by 270

CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer

Liu, T., Sun, B., Zhao, X., Zhao, X. M., Sun, T., Gu, Q., Yao, Z., Dong, X., Zhao, N., & Liu, N. (2012) · Oncogene · doi:10.1038/onc.2012.85 · Cited by 270

Hypoxia-inducible factor 3 biology: complexities and emerging themes

Duan, C. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00315.2015 · Cited by 269

Regulation of MAP kinases by MAP kinase phosphatases

Kondoh, K., & Nishida, E. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.002 · Cited by 268

Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells

Zhang, C., Zhi, W. I., Lu, H., Samanta, D., Chen, I., Gabrielson, E., & Semenza, G. L. (2016) · Oncotarget · doi:10.18632/oncotarget.11743 · Cited by 266

Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase

Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3073 · Cited by 266

Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.

Kitadai, Y., Haruma, K., Sumii, K., Yamamoto, S., Ue, T., Yokozaki, H., Yasui, W., Ohmoto, Y., Kajiyama, G., Fidler, I. J., et al. (1998) · Europe PMC (PubMed Central) · Cited by 265

DUSPs, to MAP kinases and beyond

Huang, C.-Y., & Tan, T.-H. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-24 · Cited by 260

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

Singh, J. K., Simões, B. M., Howell, S. J., Farnie, G., & Clarke, R. B. (2013) · Breast Cancer Research · doi:10.1186/bcr3436 · Cited by 255

Programmed cell removal: a new obstacle in the road to developing cancer

Chao, M. P., Majeti, R., & Weissman, I. L. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3171 · Cited by 246

Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors

Qi, J., Nakayama, K., Cardiff, R. D., Borowsky, A. D., Kaul, K. L., Williams, R. M., Krajewski, S., Mercola, D., Carpenter, P. M., Bowtell, D. D. L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.024 · Cited by 236

Sequence specificity of the human mRNA N6-adenosine methylasein vitro

Harper, J. E., Miceli, S. M., Roberts, R. J., & Manley, J. L. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.19.5735 · Cited by 235

Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells.

Elner, V. M., Strieter, R. M., Elner, V. M., Baggiolini, M., Lindley, I. J. D., & Kunkel, S. L. (1990) · Europe PMC (PubMed Central) · Cited by 233

Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells

Espinoza, I. C., & Miele, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.027 · Cited by 233

Cancer stem cells: In the line of fire

Alison, M. R., Lin, W., Lim, S. M. L., & Nicholson, L. J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.003 · Cited by 228

Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression

Luo, W., Chang, R., Zhong, J., Pandey, A., & Semenza, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217394109 · Cited by 228

IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells

Freund, A., Chauveau, C., Brouillet, J., Lucas, A., Lacroix, M., Licznar, A., Vignon, F., & Lazennec, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206113 · Cited by 225

Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers

Hwang‐Verslues, W. W., Kuo, W., Chang, P.-H., Pan, C.-C., Wang, H., Tsai, S., Jeng, Y., Shew, J., Kung, J. T., Chen, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008377 · Cited by 224

Oxygen Sensing and Homeostasis

Prabhakar, N. R., & Semenza, G. L. (2015) · Physiology · doi:10.1152/physiol.00022.2015 · Cited by 223

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.

Inoue, K., Slaton, J. W., Kim, S. J., Perrotte, P., Eve, B. Y., Bar‐Eli, M., Radinsky, R., & Dinney, C. P. (2000) · PubMed · Cited by 222

Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer

Schwab, L. P., Peacock, D. L., Majumdar, D., Ingels, J. F., Jensen, L. C., Smith, K., Cushing, R. C., & Seagroves, T. N. (2012) · Breast Cancer Research · doi:10.1186/bcr3087 · Cited by 220

Multidrug Resistance

Pastan, I. H., & Gottesman, M. M. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.001425 · Cited by 220

Octamer 4 Small Interfering RNA Results in Cancer Stem Cell–Like Cell Apoptosis

Hu, T., Liu, S., Breiter, D. R., Wang, F., Tang, Y., & Sun, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6642 · Cited by 220

DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation

Dango, S., Mosammaparast, N., Sowa, M. E., Xiong, L.-J., Wu, F., Park, K., Rubin, M., Gygi, S., Harper, J. W., & Shi, Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.039 · Cited by 216

Chemokine Receptors CXCR-1/2 Activate Mitogen-activated Protein Kinase via the Epidermal Growth Factor Receptor in Ovarian Cancer Cells

Venkatakrishnan, G., Salgia, R., & Groopman, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6868 · Cited by 211

Hes1: a key role in stemness, metastasis and multidrug resistance

Liu, Z.-H., Dai, X., & Du, B. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1016662 · Cited by 198

Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres

Méndez, O., Zavadil, J., Esencay, M., Lukyanov, Y., Santovasi, D., Wang, S., Newcomb, E. W., & Zagzag, D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-133 · Cited by 198

High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival.

Friedrichs, K., Ruiz, P., Franke, F. A., Gille, I., Terpe, H.-J., & Imhof, B. A. (1995) · PubMed · Cited by 195

Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines

Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S., Hamada, H., Yoshikawa, H., Kondo, T., & Bannai, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600786 · Cited by 191

Mammalian homologs of seven in absentia regulate DCC via the ubiquitin–proteasome pathwayPreprint

Hu, G., Zhang, S., Vidal, M., Baer, J. L., Xu, T., & Fearon, E. R. (1997) · Genes & Development · doi:10.1101/gad.11.20.2701 · Cited by 191

The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia

Przanowski, P., Dąbrowski, M., Ellert‐Miklaszewska, A., Kloss, M., Mieczkowski, J., Kaza, B., Ronowicz, A., Hu, F., Piotrowski, A., Kettenmann, H., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1090-5 · Cited by 189

Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer

Thakur, R. K., Trivedi, R., Rastogi, N., Singh, M., & Mishra, D. P. (2015) · Scientific Reports · doi:10.1038/srep10194 · Cited by 187

Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment

Lu, H., Chen, I., Shimoda, L. A., Park, Y., Zhang, C., Tran, L., Zhang, H., & Semenza, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.001 · Cited by 173

IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts.

Schröder, J. ‐., Sticherling, M., Henneicke, H. H., Preissner, W. C., & Christophers, E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.6.2223 · Cited by 170

Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells

Xu, X., Tan, X., Tampe, B., Sanchez, E., Zeisberg, M., & Zeisberg, E. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636944 · Cited by 169

An Undesired Effect of Chemotherapy

Arora, S., Bhardwaj, A., Singh, S., Srivastava, S. K., McClellan, S., Nirodi, C. S., Piazza, G. A., Grizzle, W. E., Owen, L. B., & Singh, A. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484576 · Cited by 166

TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma

Mariani, C. J., Vasanthakumar, A., Madžo, J., Yesilkanal, A. E., Bhagat, T. D., Yu, Y., Bhattacharyya, S., Wenger, R. H., Cohn, S. L., Nanduri, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.040 · Cited by 165

Yeast targets for mRNA methylation

Bódi, Z., Button, J. D., Grierson, D. S., & Fray, R. G. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq266 · Cited by 160

Human AlkB Homologue 5 Is a Nuclear 2-Oxoglutarate Dependent Oxygenase and a Direct Target of Hypoxia-Inducible Factor 1α (HIF-1α)

Thalhammer, A., Bencokova, Z., Poole, R., Loenarz, C., Adam, J., O′Flaherty, L., Schödel, J., Mole, D. R., Giaslakiotis, K., Schofield, C. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016210 · Cited by 154

Tissue distribution of drug-metabolizing enzymes in humans

Pacifici, G. M., Franchi, M. P., Bencini, C., Repetti, F., Lascio, N. D., & Muraro, G. B. (1988) · Xenobiotica · doi:10.3109/00498258809041723 · Cited by 150

Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration

Zhang, Y., Sime, W., Juhas, M., & Sjölander, A. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.005 · Cited by 146

Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression

Jung, J., Park, S., Lee, S., Seo, M., Trosko, J. E., & Kang, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028068 · Cited by 145

MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha

Zhang, H., Pu, J., Qi, T., Qi, M., Yang, C., Li, S., Huang, K., Zheng, L., & Tong, Q. (2014) · Oncogene · doi:10.1038/onc.2012.574 · Cited by 144

Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP)

Gregory, H., Young, J. A., Schröder, J., Mrowietz, U., & Christophers, E. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80364-4 · Cited by 141

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

Ghosh, A. K., Shanafelt, T. D., Cimmino, A., Taccioli, C., Volinia, S., Liu, C., Calin, G. A., Croce, C. M., Chan, D. A., Giaccia, A. J., et al. (2009) · Blood · doi:10.1182/blood-2008-10-185686 · Cited by 139

Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM)

Wang, R., Lai-xiu, Y., Shen, L., Ye, D., Yang, L., Liu, Q., Zhao, Z., Cai, Q., Tan, J., & Li, X. (2018) · Medical Science Monitor · doi:10.12659/msm.908022 · Cited by 139

Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis

Wu, M.-Z., Chen, S.-F., Nieh, S., Benner, C. W., Ger, L., Jan, C., Ma, L., Chen, C., Hishida, T., Chang, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3208 · Cited by 136

Emerging role of nanog in tumorigenesis and cancer stem cells

Santaliz-Ruiz, L. E. I., Xie, X., Old, M. O., Teknos, T. N., & Pan, Q. (2013) · International Journal of Cancer · doi:10.1002/ijc.28690 · Cited by 136

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

Krishnamachary, B., Penet, M., Nimmagadda, S., Mironchik, Y., Raman, V., Solaiyappan, M., Semenza, G. L., Pomper, M. G., & Bhujwalla, Z. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044078 · Cited by 132

ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion

Vendrell, J. A., Thollet, A., Nguyen, N. T., Ghayad, S. E., Vinot, S., Bièche, I., Grisard, E., Josserand, V., Coll, J., Roux, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3095 · Cited by 131

Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell Activity

D'Angelo, R. C., Ouzounova, M., Davis, A., Choi, D., Tchuenkam, S. M., Kim, G., Luther, T. K., Quraishi, A. A., Şenbabaoğlu, Y., Conley, S. J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0228 · Cited by 127

Glutathione S-conjugates as prodrugs to target drug-resistant tumors

Ramsay, E. E., & Dilda, P. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00181 · Cited by 126

Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression

Qin, J., Liu, Y., Lu, Y., Liu, M., Li, M., Li, J., & Wu, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09244-8 · Cited by 121

HypoxamiRs and Cancer: From Biology to Targeted Therapy

Gee, H. E., Ivan, C., Călin, G. A., & Ivan, M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5639 · Cited by 119

Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype

Xiang, L., Gilkes, D. M., Hu, H., Takano, N., Luo, W., Lu, H., Bullen, J. W., Samanta, D., Liang, H., & Semenza, G. L. (2014) · Oncotarget · doi:10.18632/oncotarget.2997 · Cited by 119

CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling

Dubrovska, A., Hartung, A., Bouchez, L. C., Walker, J. R., Reddy, V. A., Cho, C. Y., & Schultz, P. G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.105 · Cited by 119

SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21 Waf1

Roperch, J.-P., Lethrone, F., Prieur, S., Piouffre, L., Israeli, D., Tuynder, M., Nemani, M., Pasturaud, P., Gendron, M., Dausset, J. B., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8070 · Cited by 118

Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self‐renewal and early development

Pedersen, M. T., Kooistra, S. M., Radzisheuskaya, A., Laugesen, A., Johansen, J. V., Hayward, D., Nilsson, J., Agger, K., & Helin, K. (2016) · The EMBO Journal · doi:10.15252/embj.201593317 · Cited by 117

Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling

Giambra, V., Jenkins, C. E., Lam, S. H. L., Hoofd, C., Belmonte, M., Wang, X., Gusscott, S., Gracias, D., & Weng, A. P. (2015) · Blood · doi:10.1182/blood-2014-10-609370 · Cited by 116

Evolution of C2H2-zinc finger genes and subfamilies in mammals: Species-specific duplication and loss of clusters, genes and effector domains

Tadepally, H. D., Burger, G., & Aubry, M. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-176 · Cited by 116

Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer

Xiang, L., Gilkes, D. M., Chaturvedi, P., Luo, W., Hu, H., Takano, N., Liang, H., & Semenza, G. L. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1102-5 · Cited by 114

Monoclonal Antibody Against Human Ovarian Tumor-Associated Antigens

Poels, L. G., Peters, D., van Megen, Y., Vooijs, G. P., Verheyen, R. N. M., Willemen, A., van Niekerk, C. C., Jap, P. H. K., Mungyer, G., & Kenemans, P. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/76.5.781 · Cited by 111

Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin

Cao, Y., Eble, J. M., Moon, E., Yuan, H., Weitzel, D. H., Landon, C. D., Yu-Chih Nien, C., Hanna, G., Rich, J. N., Provenzale, J. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1345 · Cited by 111

Experimental therapeutics: targeting the redox Achilles heel of cancer.

Cabello, C. M., Bair, W. B., & Wondrak, G. T. (2007) · PubMed · Cited by 110

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics

Dang, H. T., Ding, W., Emerson, D., & Rountree, C. B. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-396 · Cited by 106

MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers

Krutilina, R. I., Sun, W., Sethuraman, A., Brown, M., Seagroves, T. N., Pfeffer, L. M., Ignatova, T. N., & Fan, M. (2014) · Breast Cancer Research · doi:10.1186/bcr3693 · Cited by 106

WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ

Chan, S. W., Lim, C. J., Huang, C.-J., Chong, Y. F., Gunaratne, H. J., Hogue, K. A., Blackstock, W. P., Harvey, K. F., & Hong, W. (2010) · Oncogene · doi:10.1038/onc.2010.438 · Cited by 104

Comprehensive Genome Sequence Analysis of a Breast Cancer AmpliconPreprint

Collins, C. C., Volik, S. V., Kowbel, D., Ginzinger, D. G., Ylstra, B., Cloutier, T., Hawkins, T. L., Predki, P. F., Martin, C., Wernick, M., et al. (2001) · Genome Research · doi:10.1101/gr.gr1743r · Cited by 104

Hypoxia-inducible factors: cancer progression and clinical translation

Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 626

HIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer

de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

Bai, R., Li, Y., Jian, L., Yue-hui, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 296

The role of hypoxia‐inducible factor 1 in tumor immune evasion

Li, Y., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimová, E., Wu, Q., & Kuča, K. (2020) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 276

Targeting Breast Cancer Stem Cells

Zhang, L., Chen, W., Liu, S., & Chen, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.76187 · Cited by 196

Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors

Semenza, G. L. (2015) · Clinical Science · doi:10.1042/cs20150451 · Cited by 52

The role of hypoxia-inducible factors in breast cancer stem cell specification

Fath, M. K., Garousi, S., Mottahedi, M., Ghasemzadeh, N., Salmani, K., Olfati, F., Saeed, M. B., Sotoudeh, S., & Barati, G. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154349 · Cited by 15

Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1

Semenza, G. L. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad061 · Cited by 26

Expression of Concern: Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors

Semenza, G. L. (2026) · Clinical Science · doi:10.1042/cs20150451_eoc

Hypoxia in Breast Cancer—Scientific Translation to Therapeutic and Diagnostic Clinical Applications

Zhang, Y., Zhang, H., Wang, M., Schmid, T., Xin, Z., Kozhuharova, L., Yu, W.-K., Huang, Y., Cai, F., & Biskup, E. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.652266 · Cited by 103